Alan R. Erickson

1.1k total citations
22 papers, 461 citations indexed

About

Alan R. Erickson is a scholar working on Rheumatology, Pathology and Forensic Medicine and Nephrology. According to data from OpenAlex, Alan R. Erickson has authored 22 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 4 papers in Pathology and Forensic Medicine and 3 papers in Nephrology. Recurrent topics in Alan R. Erickson's work include Rheumatoid Arthritis Research and Therapies (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Gout, Hyperuricemia, Uric Acid (3 papers). Alan R. Erickson is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Gout, Hyperuricemia, Uric Acid (3 papers). Alan R. Erickson collaborates with scholars based in United States. Alan R. Erickson's co-authors include Sterling G. West, Scott A. Vogelgesang, Raymond J. Enzenauer, Vishnu Reddy, Marisa S. Klein‐Gitelman, Karla Jones, Daniel F. Battafarano, Marcy B. Bolster, John FitzGerald and Jonathan S. Hausmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Medicine and Journal of Periodontology.

In The Last Decade

Alan R. Erickson

22 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan R. Erickson United States 9 264 95 68 54 52 22 461
César Alejandro Arce-Salinas Mexico 12 388 1.5× 71 0.7× 75 1.1× 37 0.7× 50 1.0× 46 605
S. Oliver United Kingdom 6 404 1.5× 197 2.1× 61 0.9× 30 0.6× 15 0.3× 6 557
KH Costenbader United States 14 443 1.7× 72 0.8× 44 0.6× 50 0.9× 29 0.6× 20 627
Ana Paula Alegretti Brazil 13 66 0.3× 98 1.0× 85 1.3× 75 1.4× 18 0.3× 42 528
Judith Sautner Austria 13 307 1.2× 100 1.1× 40 0.6× 90 1.7× 43 0.8× 39 494
Janice Mooney United Kingdom 7 180 0.7× 44 0.5× 26 0.4× 33 0.6× 29 0.6× 14 381
D. Tin Canada 15 592 2.2× 194 2.0× 42 0.6× 19 0.4× 15 0.3× 59 731
Sedat Yılmaz Türkiye 14 202 0.8× 77 0.8× 23 0.3× 87 1.6× 18 0.3× 100 630
İsmail Şimşek Türkiye 15 258 1.0× 111 1.2× 19 0.3× 96 1.8× 18 0.3× 49 677
Nataliya Milman Canada 12 293 1.1× 52 0.5× 16 0.2× 29 0.5× 31 0.6× 31 475

Countries citing papers authored by Alan R. Erickson

Since Specialization
Citations

This map shows the geographic impact of Alan R. Erickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan R. Erickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan R. Erickson more than expected).

Fields of papers citing papers by Alan R. Erickson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan R. Erickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan R. Erickson. The network helps show where Alan R. Erickson may publish in the future.

Co-authorship network of co-authors of Alan R. Erickson

This figure shows the co-authorship network connecting the top 25 collaborators of Alan R. Erickson. A scholar is included among the top collaborators of Alan R. Erickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan R. Erickson. Alan R. Erickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Punjabi, Omar S., et al.. (2023). Vogt-Koyanagi-Harada-like Syndrome Induced by Checkpoint Inhibitor Cemiplimab. Journal of Immunotherapy. 46(8). 295–298. 6 indexed citations
2.
Foster, Kirk, et al.. (2022). Hydroxychloroquine and Fabry Disease: Three Case Reports Examining an Unexpected Pathologic Link and a Review of the Literature. SHILAP Revista de lepidopterología. 2022. 1–6. 3 indexed citations
3.
Romberger, Debra J., et al.. (2020). Infliximab Treatment of Refractory Cardiac Sarcoidosis. SHILAP Revista de lepidopterología. 2(10). 1553–1557. 2 indexed citations
4.
Erickson, Alan R.. (2019). Human Learning, Memory, and Student Development. 2 indexed citations
5.
Erickson, Alan R., et al.. (2019). Spontaneous resolution of idiopathic aortitis and pitfalls in diagnosis. Journal of Vascular Surgery Cases and Innovative Techniques. 5(2). 95–98. 1 indexed citations
6.
Erickson, Alan R., et al.. (2019). IgG-4 Related Disease: An Introduction.. PubMed. 115(3). 253–256. 23 indexed citations
7.
Cannon, Grant W., Alan R. Erickson, Chia‐Chen Teng, et al.. (2019). Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort study. Rheumatology Advances in Practice. 3(1). rkz015–rkz015. 1 indexed citations
8.
Battafarano, Daniel F., Marcia Ditmyer, Marcy B. Bolster, et al.. (2018). 2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015–2030. Arthritis Care & Research. 70(4). 617–626. 173 indexed citations
9.
Danve, Abhijeet, Rana Zabad, & Alan R. Erickson. (2017). Intravenous Immunoglobulin for Mixed Connective Tissue Disease Presenting With Bilateral Trigeminal Neuropathy. American Journal of Therapeutics. 25(3). e383–e385. 5 indexed citations
10.
Solow, E. Blair, Fang Yu, Geoffrey M. Thiele, et al.. (2015). Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors and mortality. Lara D. Veeken. 54(9). 1587–1595. 7 indexed citations
11.
Gonzalez, Shawneen M., Jeffrey B. Payne, Fang Yu, et al.. (2014). Alveolar Bone Loss Is Associated With Circulating Anti‐Citrullinated Protein Antibody (ACPA) in Patients With Rheumatoid Arthritis. Journal of Periodontology. 86(2). 222–231. 40 indexed citations
12.
Feely, Michael G, Alan R. Erickson, & James R. O’Dell. (2009). Therapeutic options for rheumatoid arthritis. Expert Opinion on Pharmacotherapy. 10(13). 2095–2106. 26 indexed citations
13.
Erickson, Alan R. & Ted R. Mikuls. (2007). Switching anti-TNF-α agents: What is the evidence?. Current Rheumatology Reports. 9(5). 416–420. 14 indexed citations
14.
Erickson, Alan R., et al.. (1998). Musculoskeletal Complaints in Persian Gulf War Veterans. JCR Journal of Clinical Rheumatology. 4(4). 181–185. 6 indexed citations
15.
Erickson, Alan R., Jane Y. Yeun, & Raymond J. Enzenauer. (1997). Chronic Calcium Pyrophosphate Crystal Deposition Disease Arthropathy Associated with Hypomagnesemia. JCR Journal of Clinical Rheumatology. 3(1). 51–53. 3 indexed citations
16.
Harris, Mark D., et al.. (1997). Prospective use of intramuscular triamcinolone acetonide in pseudogout.. PubMed. 24(6). 1168–70. 29 indexed citations
17.
Erickson, Alan R., et al.. (1997). Variability of Treatment for Gouty Arthritis Between Rheumatologists and Primary Care Physicians. JCR Journal of Clinical Rheumatology. 3(1). 24–27. 9 indexed citations
18.
McGovern, Thomas W., Alan R. Erickson, & James E. Fitzpatrick. (1996). Sjögren's syndrome plasma cell panniculitis and hidradenitis. Journal of Cutaneous Pathology. 23(2). 170–174. 7 indexed citations
19.
Erickson, Alan R., Vishnu Reddy, Scott A. Vogelgesang, & Sterling G. West. (1995). Usefulness of the american college of rheumatology recommendations for liver biopsy in methotrexate‐treated rheumatoid arthritis patients. Arthritis & Rheumatism. 38(8). 1115–1119. 59 indexed citations
20.
Erickson, Alan R., et al.. (1994). The prevalence of hypothyroidism in gout. The American Journal of Medicine. 97(3). 231–234. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by César Alejandro Arce-Salinas Breakdown of academic impact, for papers by S. Oliver Breakdown of academic impact, for papers by KH Costenbader Breakdown of academic impact, for papers by Ana Paula Alegretti Breakdown of academic impact, for papers by Judith Sautner Breakdown of academic impact, for papers by Janice Mooney Breakdown of academic impact, for papers by D. Tin Breakdown of academic impact, for papers by Sedat Yılmaz Breakdown of academic impact, for papers by İsmail Şimşek Breakdown of academic impact, for papers by Nataliya Milman
Rankless by CCL
2026